Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
ORIGINAL ARTICLE
Ahead of Print

Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis


1 Department of Internal Medicine, Hospital of Jinghu, Wuhu, China
2 Department of Health Inspection and Quarantine, School of Public Health, Anhui Medical University, Hefei, Anhui, China
3 Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
4 Department of Child and Maternal Health, School of Public Health, Anhui Medical University, Hefei, Anhui, China

Correspondence Address:
Yihong Cai,
Department of Health Inspection and Quarantine, School of Public Health, Anhui Medical University, Hefei, Anhui
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Objective: To quantitatively investigate the effect of GSTP1 hypermethylation on hepatocellular carcinoma (HCC) using a meta-analysis of available case–control studies. Materials and Methods: Previous studies have primarily evaluated the incidence of GSTP1 hypermethylation in HCC and corresponding control groups, and compared the incidence of GSTP1 hypermethylation in tumor tissues, pericancer liver tissues, normal liver issues, and nontumor liver tissues with that in other diseases. Data regarding publication information, study characteristics, and incidence of GSTP1 hypermethylation in both groups were collected from these studies and summarized. Eleven studies, including 546 cases of HCC and 575 nontumor cases, were identified for meta-analysis. Results: Statistically significant odds ratios (ORs) of GSTP1 hypermethylation were obtained from tumor tissues and nontumorous liver tissues of HCC patients (OR 2.63, 95% confidence interval [CI]: 1.77–3.89%, P < 0.0001), tumor tissues of HCC patients, healthy liver tissues of patients with other diseases (OR 7.29, 95% CI: 2.87–18.51%, P < 0.0001), tumor tissues of HCC patients, and liver tissues of patients with nontumorous liver diseases (OR 2.13, 95% CI: 1.10–4.13%, P < 0.05). The pooled analysis showed significantly increased ORs of GSTP1 hypermethylation (OR 2.21, 95% CI: 1.01–4.84%, P < 0.05) from HCC tissues and cirrhotic tissues. Conclusions: The results of this meta-analysis suggest that GSTP1 hypermethylation induces the inactivation of GSTP1 gene, plays an important role in hepatocarcinogenesis, and is associated with an increased risk of HCC.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Li Y
    -  Cai Y
    -  Chen H
    -  Mao L
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed137    
    PDF Downloaded12    

Recommend this journal